The tumor suppressor protein p53 has a transcriptional activation activity thought to mediate its biologic function including G 1 arrest and perhaps apoptosis. To learn more about p53's transactivator function in vivo, we performed genomic footprinting experiments examining p53-DNA interactions in the regulatory regions of the p53-regulated genes p21, GADD45, and MDM2. Using ionizing radiation to induce DNA damage in human ML-1 myeloblastic leukemia cells, the promoter and intronic regions of these genes containing p53-consensus binding sites were examined for in vivo footprints. There was a uniform and sustained expression of p53 protein as well as a strong induction of p21, GADD45, and MDM2 mRNA following irradiation. At the two p53 consensus binding sites in the p21 promoter, reduced DNaseI cleavage was observed in irradiated cells beginning 1 to 2 h after irradiation, being most pronounced after 2 h and diminishing after 8 h. A partial in vivo footprint was also observed in the third intron of the GADD45 gene beginning 2 h after irradiation. No in vivo footprints were seen at the two p53 binding sites in the MDM2 gene. Our study provides direct evidence that the DNA damage-induced activity of p53 is mediated by its consensus DNA binding sites in the p21 and GADD45 genes. We suggest that the transient nature and relative instability of p53-DNA interactions in vivo may make the p53 protein more accessible to a rapid turnover pathway which might be impaired under conditions when the protein is stably bound to DNA.
Introduction
The p53 gene is the most commonly mutated gene in human tumors and codes for a nuclear protein which is involved in various aspects of cell growth (reviewed in Levine et al., 1991; Vogelstein and Kinzler, 1992; Gottlieb and Oren, 1996; Harris, 1996; Ko and Prives, 1996) . The p53 protein acts as a tumor suppressor and has been described as a sequence-speci®c transcription factor regulating gene expression. The consensus binding site was derived empirically and is a repeating 10 bp motif . This binding site has been described in several p53 target genes currently under investigation. An understanding of the p53 protein-DNA interactions in these target genes is vital in clarifying p53's function.
Following exposure to a variety of DNA damaging agents, intracellular levels of p53 protein increase (Maltzman and Czyzyk, 1984; Kastan et al., 1991; Lu and Lane, 1993) . With this increase, p53 protein has a critical role in the induction of a speci®c G1 arrest after exposure to ionizing radiation (Kastan et al., 1991) . This block to cell cycle progression following genomic DNA damage is thought to protect the genome from acquiring excess mutations and p53 has been described as a`guardian of the genome' (Lane, 1992 ). p53 appears to mediate many of these biologic eects as a transcriptional activator . Characterization of the transcriptional target genes responsible for cell growth delay, cell cycle checkpoints, and apoptosis is the subject of much interest.
One of the most studied genes is the p21/WAF1/ SDI1/CIP1 gene, subsequently called p21. The gene codes for a protein of M r 21 000 which has a potent inhibitory eect on cyclin-dependent kinases (Cdks) in vitro (El-Deiry et al., 1993; , Harper et al., 1993 , Xiong et al., 1993 . By inhibiting Cdks, particularly those that function at the G 1 /S checkpoint of the cell cycle, p21 may exert its control over cell growth. Cells which undergo a G 1 arrest after exposure to ionizing radiation show an increase of p21 which is due, at least in part, to a p53-dependent induction (El-Diery et al., 1994; Bae et al., 1995; Di Leonardo et al., 1994; Dulic et al., 1994) . Two p53 consensus binding sites have been described in the p21 promoter located at 71.3 kb and 72.2 kb upstream from the ®rst exon and are thought to participate in the induction (El-Deiry et al., 1995) .
The Growth Arrest and DNA Damage GADD genes are a group of genes induced by DNA-damaging agents and some growth arrest conditions (Fornace et al., 1989) . A member of this family of genes, GADD45, is inducible by ionizing radiation (Zhan et al., 1993; Carrier et al., 1994) . Although its function is not fully elucidated, the product of the GADD45 gene interacts directly with the essential replication and repair factor PCNA, inhibiting the entry of cells into S phase . By this block of DNA replication, GADD45 may facilitate nucleotide excision repair of DNA damage. The induction of GADD45 in response to DNA damage is thought to be mediated in several cell types by p53 (Kastan et al., 1992) . The GADD45 gene contains a p53 consensus binding site in its third intron which may stimulate the induction (Hollander et al., 1993) .
The proto-oncogene MDM2 (mouse double minute 2) is ampli®ed in various tumors including 22% of human soft tissue tumors (Oliner et al., 1992; Momand and Zambetti, 1997) . It encodes a protein that complexes with p53 eliminating its transcriptional activation ability (Momand et al., 1992; Oliner et al., 1993; Momand and Zambetti, 1996) . The MDM2 gene is itself a transcriptional target of p53 and can be induced by u.v. light and ionizing radiation in a p53-dependent manner (Perry et al., 1993; Price and Park, 1994; Chen et al., 1994) . Thus, as its expression is induced by p53 and its gene product abolishes p53 transactivator function, MDM2 is coupled to p53 in an autoregulatory feedback loop (Wu et al., 1993, Zambetti and . The ®rst intron of the MDM2 gene contains two tandem p53 binding elements thought to mediate induction by p53 (Zauberman et al., 1995) .
Much of the information regarding p53 binding to these consensus binding sites was derived from transfection assays using target constructs and gel mobility shift assays or in vitro footprint analyses using nuclear extracts or puri®ed protein. In an eort to Figure 1 Immunohistochemical staining showing inducibility of p53 with ionizing radiation in ML-1 cells. ML-1 cells were exposed to 20 Gy of ionizing radiation. An untreated sample was the 0 h control (a). The cells were reincubated and harvested at 1, 2, 4 and 8 h post-irradiation (b, c, d, e, respectively) . The cells were ®xed in formalin and mounted in paran blocks. Anti-p53 antibody DO1 and an anti-E1A antibody (as a negative control; shown in f) were used as primary antibodies for immuno-histochemical staining. There is a progressive increase in p53 staining with increasing incubation time, peaking at 2 and 4 h post-irradiation followed by a decrease in staining at 8 h better understand the p53 protein-DNA interactions during normal cell growth in vivo, we have exposed human ML-1 cells (myeloblastic leukemia cells) to ionizing radiation in order to induce DNA damage and subsequent ampli®cation of p53 protein levels. We veri®ed the ampli®cation of p53 protein levels by immunohistochemical analysis and the induction of the p53-inducible genes p21, GADD45 and MDM2 using Northern blot analyses. Using the technique of ligation-mediated polymerase chain reaction (LMPCR) and in vivo genomic footprinting using dimethylsulfate (DMS) and DNaseI, we examined the promoters and intronic elements of the p21, GADD45 and MDM2 genes containing p53 binding sites in an eort to demonstrate footprints associated with p53-DNA interactions. It was our expectation to characterize the nature of p53 transactivator activity in an in vivo setting.
Results

Induction of p53 protein expressing by ionizing radiation in ML-1 cells
The ML-1 human myelogenous leukemia cell line has been demonstrated to have a strong induction of GADD45 (Kastan et al., 1992; Zhan et al., 1994; Carrier et al., 1994) and MDM2 when exposed to ionizing radiation and of p21 when exposed to adriamycin (Zeng and El-Deiry, 1996) or actinomycin D (Moll et al., 1996) . The induction of these genes correlates with an induction of wild-type p53 and it has been suggested that p53 acts as a transcription factor in this induction. To determine if p53 is expressed after DNA damage and if this expression occurs in the majority of cells in the cell population, ML-1 cells were exposed to 20 Gy of ionizing radiation, reincubated at 378C, and harvested at 1, 2, 4 and 8 h post-irradiation. The cells were ®xed in formalin and mounted in paran blocks, then stained using the DO1 anti-p53 antibody as described in the Materials and methods section. Untreated ML-1 cells and cells stained with an anti-E1A antibody were used as controls. Figure 1 shows progressively increased antibody staining for p53 in ML-1 cells with increased incubation post-irradiation. For the 0 h control there is minimal p53 staining. At 1 h there is a staining of approximately 50% of the cell population which increases to 490% at 2 and 4 h before decreasing back to 50% at 8 h. An anti-E1A antibody-stained sample as a negative control is presented for comparison. Thus, under DNA damaging conditions using ionizing radiation, 490% of the cell population shows p53 induction. Such a homogenous response of the population is an important requirement for genomic footprinting experiments.
Induction of p21, GADD45 and MDM2 in ML-1 cells by ionizing radiation Northern blot analysis was performed on ML-1 cells to examine the expression of the p53-inducible genes after DNA damage (Figure 2 ). ML-1 cells were exposed to ionizing radiation and total RNA was collected at 1, 2, 4 and 8 h after reincubation at 378C along with an untreated control and subjected to Northern blot analysis. Figure 2 shows a progressively increased induction of p21, GADD45 and MDM2 mRNA as postirradiation incubation time increases with a peak generally at 2 to 4 h post-irradiation. There may be a subsequent decrease at 8 h, however, dierences in sample loading may account in part for this decrease. The strongest induction is for p21 followed by MDM2 and GADD45, respectively. There are two new smaller mRNA transcripts induced at 2 and 4 h post-irradiation for MDM2. The GADD45 gene shows a new transcript beginning 1 h after irradiation. Northern blot analysis showing induction by ionizing radiation of p21, GADD45 and MDM2 RNA in ML-1 cells. ML-1 cells were exposed to 20 Gy ionizing radiation. Cells were then reincubated and harvested at the indicated time points, total cellular RNA was extracted, separated on a 1% agarose gel, transferred to a nylon membrane and hybridized with probes speci®c for p21, GADD45 MDM2 and GADPH Genomic footprinting of the p21 promoter in ML-1 cells with DMS An eort was made to determine if the increased expression of the p21 gene after ionizing radiation treatment was mediated by p53 binding to the p53 consensus binding site located 1.3 kb upstream of the transcription start site (El Deiry et al., 1995) . In vivo footprint analysis of the p21 gene in the region of the p53 binding site was initially performed using dimethylsulfate (DMS), a technique that is used most commonly for in vivo footprinting experiments Pfeifer, 1992) . DMS is a small molecule that diuses easily through cell membranes to react with nuclear DNA forming methylated bases (predominantly 7-methylguanines). After DMS treatment and DNA isolation, hot piperidine was used to cleave the DNA at the modi®ed bases. The cleaved DNA fragments were then ampli®ed using ligationmediated polymerase chain reaction (LMPCR; Mueller and Wold, 1989; Pfeifer et al., 1989 Pfeifer et al., , 1990 Pfeifer and Riggs, 1996) with p21-speci®c primers and separated on polyacrylamide gels. Dierences in the modi®cation patterns between DMS-treated cells and DMS-treated naked DNA controls would demonstrate in vivo protein-DNA interactions. ML-1 cells were irradiated with 20 Gy of ionizing radiation, the cells reincubated, then harvested at 1, 2, 4 and 8 h post-irradiation for DMS treatment. LMPCR primers were designed to¯ank one of the two p53 consensus binding sites located within the p21 promoter (El-Deiry et al., 1995) . Figure 3 shows (a) the upper strand and (b) the lower strand of the p21 promoter spanning nt 71310 to 71400 and 71260 to 71375, respectively, upstream of the major transcription initiation site. The p53 binding sites are indicated by brackets. Neither the upper nor lower DNA strand show DMS footprints within the p53 binding site. Also, no footprints are noted in the vicinity of the p53 binding site for this region of the p21 promoter.
Genomic footprinting in ML-1 cells with DNaseI
Due to the lack of footprints demonstrated using DMS, another method of footprinting was employed, DNaseI genomic footprinting (Pfeifer and Riggs, 1991) . DNaseI is less base selective than DMS, is more sensitive to minor groove protein-DNA contacts, provides information on chromatin structure, and exhibits larger and clearer footprints than DMS. In order to perform DNaseI genomic footprinting, cells were permeabilized with lysolecithin to allow access of the DNaseI to the nuclei. In order to minimize the nonspeci®c background during ampli®cation of the genomic fragments generated by DNaseI cleavage, a modi®ed LMPCR method using extension product capture was used . To perform the DNaseI genomic footprinting analysis, ML-1 cells were exposed to 20 Gy ionizing radiation, incubated at 378C, and harvested at 1, 2, 4 and 8 h post-irradiation. The cells were permeabilized with lysolecithin, treated with DNaseI, and the DNA extracted. The primers used for LMPCR were designed to¯ank p53 consensus binding sites within the p21 promoter, GADD45 gene, and MDM2 gene.
(a) p21 promoter
We ®rst analysed the p53 consensus binding site located 1.3 kb upstream of the transcription start site of the p21 gene (Figure 4) . Beginning 2 h after irradiation there is a partial reduction of band intensities within an area that contains the p53 consensus DNA binding site (indicated by a dotted line in Figure 4a and confirmed by phosphorimaging in Figure 4b ). Adjacent to the footprinted area, a DNaseI hypersensitive site becomes apparent 2 h after irradiation. Thus, p53 protein-DNA interactions could be detected by DNaseI footprinting, but were missed using the more commonly used DMS footprinting technique. The partial protection from DNaseI cleavage is transient and has mostly disappeared 8 h after irradiation (Figure 4) . Figure 5 shows the lower strand of the p21 promoter spanning nt 72165 to 72260 upstream of the major transcription initiation site and¯anking the more upstream of the two p53 binding sites in the p21 promoter. The consensus binding site is indicated by a bracket. Also here, there is reduced DNaseI cutting after ionizing radiation within the p53 consensus site (dotted lines in Figure 5 ). The strongest protection is seen 2 h after irradiation. Figure 5b shows a phosphorimager scan of the same region containing the p53 binding site.
(b) GADD45 gene Figure 6 shows the lower strand of the region spanning nt. 1550 to 1645 downstream from the major transcription start site of the GADD45 gene. The p53 site is located within the third intron of the GADD45 gene (Figure 6a, indicated by a bracket) . There is a reduction of DNaseI cleavage within the p53 binding site beginning about 2 h after ionizing radiation treatment. The extent of DNaseI protection is less than at the p53 binding sites in the p21 gene but becomes more obvious after phosphorimaging ( Figure  6b ). This partial protection is diminished after 8 h. A weak partial protection was also seen on the opposite DNA strand (data not shown).
(c) MDM2 gene Figure 7 shows the region of the MDM2 gene spanning nt 100 to 245 of a sequenced region within intron 1 (Zauberman et al., 1995; GenBank accession number U28935). This region within the ®rst intron of the MDM2 gene contains two p53 binding sites which are delineated by brackets. In this case, no DNaseI footprints were detected within either binding site or in the vicinity of either binding site on either of the two DNA strands. In addition, DNaseI cleavage is very similar between naked DNA controls and in vivo treated samples indicating that this region is free of sequence-speci®c binding proteins and does not contain positioned nucleosomes.
The presence of only partial DNaseI footprints in the p21 and GADD45 genes and the lack of footprints in the MDM2 gene raised the concern that, for technical reasons, our DNaseI footprinting technique resulted in unstable protein-DNA complexes or detachment of complexes. To control for the ability of the DNaseI footprinting technique to detect bound transcription factors, the promoter of the JUN gene, which has characteristic DNaseI footprints (Rozek and Pfeifer, 1993) was examined with the same DNA samples. Figure 8 shows DNaseI genomic footprinting of the JUN promoter in a region spanning nt 725 to 7125 upstream from the major transcription start site. This sequence reveals clear footprints within the consensus binding sites for transcription factors RSRF, AP-1, Sp1 and a partial occupation of the CCAAT box sequence similar as previously described (Rozek and Pfeifer, 1993) . No signi®cant change in footprints was observed after ionizing radiation treatment.
Discussion
There is ample evidence in the literature for the transcriptional activator role of p53. After the induction of increased p53 protein levels following DNA damage, there is a corresponding induction of the p53-regulated genes p21, GADD45 and MDM2. A role of p53 protein in this induction by binding to its consensus binding sites within the p21 promoter has been demonstrated using cotransfection experiments with p53 wild type and mutant expression plasmids and reporter plasmid constructs (El-Deiry et al., 1993) , mobility shift assays (Liu and Pelling, 1995) and transfection experiments with deletion target constructs (El-Deiry et al., 1995) . The induction of GADD45 has been shown to be dependent on a wildtype p53 phenotype Carrier et al., 1994) and evidence supporting wild-type p53 binding to its consensus binding site within the third intron of the GADD45 gene has been provided by immunoprecipitation, cotransfection, and gel mobility shift assays (Kastan et al., 1992) . For MDM2, cells transfected with a CAT reporter construct containing the ®rst intron of MDM2 and treated with u.v. light (Perry et al., 1993) , or cotransfected with a wild-type p53 expression plasmid (Wu et al., 1993; Zauberman et al., 1995) demonstrated responses consistent with p53-dependent induction. This evidence is highly suggestive in implicating the p53 consensus binding sites as mediators of p53 transcriptional activation.
Recent reports, however, also demonstrate p53-independent activation of these genes as well. There has been signi®cant work demonstrating p53-independent pathways for induction of p21. Mouse models that involve p53-de®cient cells demonstrated p53-independent induction of p21/WAF1/CIP1 in response (Zeng and El-Deiry, 1996) ; mimosine, a G 1 phase blocker induces a p53-independent p21 pathway in human breast cancer cells (Alpan and Pardee, 1996); diethylmaleate-induced oxidative stress (which is expected to cause similar types of DNA damage as ionizing radiation does) in Saos-2 and T98G cells, which both lack functional p53, induced expression of p21 (Russo et al., 1995) . A variety of human tumors and cell lines have demonstrated p53-independent p21 induction: human breast cancer cells treated with serum starvation, the DNA damaging agent etoposide or the retinoid AHPN (Sheikh et al., 1994; Shao et al., 1995) ; gamma irradiation of KG-1 human myeloblastic leukemia cells and other cells which lack p53 or contain mutant p53 (Akashi et al., 1995) ; and adriamycin treatment of HTLV-I transformed lymphocytes (Gartenhaus et al., 1996) .
Evidence for p53-independent GADD45 induction also exists (Canman et al., 1995) . Many (80%) melanoma cell lines with wild type p53, fail to induce GADD45 after exposure to ionizing radiation (Bae et al., 1996) . In CHO cells, a co-transfection of the human GADD45 gene and a wild-type p53 expression vector failed to show transcriptional activation of the GADD45 gene despite overexpression of p53 (Hollander et al., 1993) . Treatment with the alkylating agent MMS or exposure to u.v. light induces GADD45 by p53-independent mechanisms (Zhan et al., 1993; Kearsey et al., 1995) . Although not as prevalent, support of p53-independent expression of MDM2 is also present. An analysis of stimulated murine lymphocytes and Swiss mouse 3T3 cells demonstrated no coordinated expression of p53 and MDM2 suggesting an independent regulation of these proteins during cellular proliferation (Mosner and Deppert, 1994) . During dierentiation of F9 embryonal carcinoma cells, wild type p53 protein is unable to transactivate the mdm-2 gene (Mayo and Berberich, 1996) . There is evidence of a greater role for enhanced translation as opposed to increased transcription accounting for the overexpression of MDM2 protein in human choriocarcinomas (Landers et al., 1994) . Finally, in a cell line completely devoid of functional p53, mdm-2 DNA ampli®cation results in a strong overexpression of mdm-2 (Momand and Zambetti, 1996) .
Our results clarify several issues regarding the mechanisms of action of p53. We studied ML-1 cells because they have been previously shown to have a strong induction of p53 to various stimuli (Kastan et al., 1991) . Northern blots revealed induction of p21, GADD45 and MDM2 mRNA after exposure of ML-1 cells to ionizing radiation. Studies using ionizing radiation and immunohistochemical staining revealed increases in p53 levels in 490% of the cell population. This apparantly excludes a cell cycle dependence for induction of p53 by DNA damage. Yet, by in vivo genomic footprinting, only partial footprints were detected at p53 consensus binding sites for two of the genes analysed and no footprints were detected for the MDM2 gene. Based on the kinetics of induction of p53 in ML-1 cells after exposure to ionizing radiation, there is a signi®cant increase in p53 protein levels starting at 1 h after irradiation, reaching a peak at 2 and 4 h before decreasing again at 8 h (Figure 1 ). These kinetics are mirrored in the induction of the p53-inducible genes p21, GADD45 and MDM2. From the Northern blots performed on these genes in ML-1 cells, peak levels of mRNA signal were reached at 2 to 4 h after irradiation before decreasing again (Figure 2 ). If these genes are indeed p53-inducible, the kinetic pro®les are consistent and support the premise of p53-DNA interactions within a speci®c time frame. Indeed, the p53-DNA interactions appear 1 to 2 h after irradiation in the p21 promoter with strongest protection from DNaseI cleavage at 2 h after irradiation and less protection at the 8 h time point (Figures 4 and 5) . Thus, induction of p53 protein, p21 mRNA levels, and p53 footprints at the p21 promoter coincide temporarilly. The p53 protein may bind its consensus binding sites in the p21 promoter brie¯y, inducing upregulation of the gene, dissassociate from the binding site, and thus would produce only a transient and partial footprint in genomic footprint analyses. This relative instability of p53-DNA interactions in vivo would make the p53 protein more accessible to a rapid turnover pathway which might be impaired when the protein is stably bound to DNA.
The complete lack of in vivo footprints at the binding sites in the MDM2 gene is unexplained at present. Although gel mobility shift and cotransfection assays suggest p53 binding to its consensus binding site in this gene, it is possible that this may not re¯ect p53 behavior in the in vivo setting. The p53 consensus binding sites analysed here may not mediate the transcriptional activation functions of p53 in vivo and other, hitherto unrecognized p53 binding sites may be involved. Alternatively, p53-independent activation pathways may dominate for the MDM2 gene under our experimental conditions. Another possibility is that p53-DNA interactions are not strong enough to be detected in this assay. This would presume that p53 interactions with MDM2 sequences are weaker than p53 interactions with the p21 and GADD45 genes. Finally, p53-independent pathways may also operate, in addition to the p53-mediated induction, in ensuring high levels of p21 and GADD45 after radiation damage.
In conclusion, our experiments provide the ®rst direct in vivo evidence for binding of p53 to its consensus binding sites in the p21 and GADD45 genes in response to DNA damage.
Materials and methods
Cell culture and u.v./IR irradiation
Myeloblastic leukemia cells (ML-1) were grown in 4% CO 2 at 378C in maintenance medium consisting of Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). Ionizing radiation was administered using a Cobalt-60 source (Theratron-80 Co-60 unit). Cells in medium were irradiated with 20 Gy of ionizing radiation, returned to the incubator, then harvested at various time points.
Immunohistochemical staining
ML-1 cells at 1610
7 cells per time point were treated with ionizing radiation (20 Gy) as described above. The cells were then harvested at various time points after irradiation by centrifugation, washed twice in PBS, ®xed in 10% formalin at room temperature for 10 min, then washed twice in PBS. The cells were then poured into 3% hot agarose molds, ®xed overnight in formalin, processed with graded alcohol and xylene, in®ltrated with paran and embedded. For staining, 4 micron thick sections were cut from the paran blocks and mounted on silane coated slides. The slides were baked at 488C overnight, rehydrated in distilled water, then blocked using 1 : 20 dilution of normal horse serum in PBS for 20 min. The slides were then incubated with various concentrations of primary antibody including the anti-p53 antibody DO1 and anti-E1A as a negative control (both obtained from Oncogene Science), followed by biotinylated IgG antibody (1 : 400), AB Complex (Vector Elite Kit, 1 : 200), DAB, 1% copper sulfate, then counterstained in Mayer's hematoxylin. The slides were then dehydrated, mounted and visualized.
RNA extraction and Northern blots
3610
6 myeloblast cells (ML-1) were treated under the experimental conditions mentioned above. The cells were harvested by centrifugation, washed in PBS, then total RNA was isolated by a guanidinium thiocyanate method (RNAzol B; Biotecx Laboratories, Inc., Houston, TX). Agarose-formaldehyde gel electrophoresis was carried out using 10 mg aliquots of each RNA sample followed by capillary transfer to nylon membranes. Membranes were hybridized at 628C in 0.25 M sodium phosphate, pH 7.2, 1 mM EDTA, 7% SDS, 1% BSA, in the presence of speci®c probes.
32 P-labeled hybridization probes were synthesized using a PCR-based technique with the following primer sets: p21A (5'-GGCCTGGCACCTCACCT GCTCT), p21B (5'-GACCCTTCAGCCTGCTCCCCTGA); GADD45A (5'-GCGACCCCGATAACGTGGTGTTGTG), GADD45B (5'-ACGCGCAGGATGTTGATGTCGTTCT); MDM2A (5'-TTTCCTTGTAGGCAAATGTGCAATACC), MDM2B (5'-TCTTGTTCCGAAGCTGGAATCTGTG). The primers are speci®c for sequences within the mRNA sequence of p21, the third exon of GADD45, and the third exon of MDM2, respectively.
In vivo footprinting with DMS and LMPCR
After centrifugation, the medium was removed from ML-1 cells and replaced with medium containing 0.2% dimethyl sulfate (Aldrich; Milwaukee, WI). The cells were incubated for 7 min at room temperature. Then, the medium was removed and the cells washed twice with ice-cold PBS. Nuclei were isolated by incubating the cells for 5 min in lysis buer A (0.3 M sucrose, 60 mM KCl, 15 mM NaCl, 60 mM Tris-Cl, pH 8.0, 0.5 mM spermidine, 0.15 mM spermine, 2 mM EDTA) with 0.5% Nonidet P40 at 48C, then washing once with buer A without Nonidet P40. DNA was isolated by resuspending nuclei in buer B (150 mM NaCl, 5 mM EDTA, pH 7.8), adding one volume of buer C (20 mM Tris-Cl, pH 8.0, 20 mM NaCl, 20 mM EDTA, 1% SDS, 600 mg/ml proteinase K), and incubating for 3 h at 378C. RNase A was added to 100 mg/ml and an additional 1 h incubation was performed. The DNA was collected by phenol/chloroform extraction and ethanol precipitation. Piperidine cleavage at methylated bases was performed by incubating the DNA in 1 M piperidine at 908C for 30 min. The chemically cleaved DNA was ampli®ed by ligation-mediated PCR (LMPCR), and the ampli®ed fragments separated on an 8% polyacrylamide-7 M urea sequencing gel in 0.1 M TBE as previously described (Pfeifer et al., 1990 Pfeifer and Riggs, 1996) . 32 P-labeled hybridization probes were synthesized by a PCR-based technique with primers p21-3 and p21-6 and p21-9 and p21-12, GADD45-3 and GADD45-6, MDM2-3 and MDM2-6, and C-3 and D-3 for the p21, GADD45, MDM2 and JUN genes, respectively. Naked DNA controls were prepared using in vitro DMS treatment on DNA harvested from ®broblast and myeloblast cells. G, G+A, T+C, and C Maxam-Gilbert (Maxam and Gilbert, 1980) reactions were performed on HeLa DNA as previously described to provide position markers (Pfeifer and Riggs, 1996) .
Gene speci®c LMPCR primer sets were selected with the aid of the Oligo TM computer program (Rychlik and Rhoads, 1989) . The following oligonucleotides were used as primers to analyse the lower strand of the p21 promoter in two regions¯anking the two consensus p53 binding sites: p21-1 (5'-TGTCCCCCAGGCTGAG), p21-2 (5'-GCTGAGCCTCC CTCCATCCCTATG), p21-3 (5'-CATCCCTATGCTGC CTGCTTCCCA) located near the 72.2 kb p53 binding site; p21-7 (5'-GGGGTCTGCTGCTGTGTC), p21-8 (5'-TGCTGCTGTGTCCTCCCACCCCTAC), p21-9 (5'-CCACCCCTACCTGGGCTCCCATCC) located near the 71.3 kb p53 binding site.
For the upper strand of the p21 promoter: p21-4 (5'-AG GTTTACCTGGGGTCTTTA), p21-5 (5'-GGGGTCTTTAG AGGTCTCCTGTCTCCTA), p21-6 (5'-CTACCATCC CCTTCCTCCCTGAAAAC) located near the 72.2 kb p53 binding site; p21-10 (5'-TCTGAACAGAAATCCCACTGA), p21-11 (5'-CCCACTGAAAAACAGAACCCAGGCTT), p21-12 (5'-GAACCCAGGCTTGGAGCAGCTACAATT) located near the 71.3 kb p53 binding site.
Similarly for the GADD45 promoter, the following oligonucleotide primers were used to analyse the lower strand: GADD45-1 (5'-GGGTCAGGAGGGTGGCT), GADD45-2 (5'-AGGGTGGCTGCCTTTGTCCGACTA), GADD45-3 (5'-TCCGACTAGAGTGTGGCTGGACT TTC). For the upper strand: GADD45-4 (5'-ATTAGT-CACGGGAGGCAGTG), GADD45-5 (5'-ACGGGAGG-C A G T G CA G A T G T A G G T A G G ) G A D D 4 5 -6 ( 5' -TGTAGGTAGGGAGTAG CTGGGCTGACT).
For the MDM2 promoter, the following primers were used for the lower strand: MDM2-1 (5'-CGGATGATCGCA GGTG), MDM2-2 (5'-GCAGGTGCCTGTCGGGTCACT A), MDM2-3 (5'-CTAGTGTGAACGCTGCGCGTAGT). For the upper strand: MDM2-4 (5'-CGGTGCTTACCTGG ATCAG), MDM2-5 (5'-TTACCTGGATCAGCAGAGAAA AAGTGG), and MDM2-6 (5'-CGTGCGTCCGTGCCCAC AG). For the JUN promoter, the primer set C-1, C-2, and C-3 and the primer D-3 have been previously described (Rozek and Pfeifer, 1993) .
In vivo footprinting with DNaseI
Myeloblast cells (ML-1) were treated at 1610 7 cells/ experimental condition, the medium removed from the cells after appropriate incubation, and the cells resuspended in solution 1 (150 mM sucrose, 80 mM KCl, 35 mM NaHEPES, pH 7.4, 5 mM K 2 HPO 4 , 5 mM MgCl 2 , 0.5 mM CaCl 2 ) and 0.05% lysolecithin type 1 (Sigma Chemical Co., St. Louis, MO) and incubated for 3 min at room temperature. After the removal of the lysolecithin solution, the cells were treated with 2 mg/ml DNaseI (Boehringer Mannheim, Indianapois, IN) in solution 2 (150 mM sucrose, 80 mM KCl, 35 mM NaHEPES, pH 7.4, 5 mM K 2 HPO 4 , 5 mM MgCl 2 , 2 mM CaCl 2 ) and incubated for 5 min at room temperature. The reaction was stopped by removing the DNaseI solution and adding buer C (see DMS footprinting above) and incubating for 3 h at 378C. The DNA was phenol/chloroform extracted and ethanol precipitated, then the RNA was removed by digestion with 50 mg/ml RNase A in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA for 2 h at 378C and the DNA collected by phenol/chloroform extraction and ethanol precipitation. The DNaseI cleavage conditions resulted in a broad distribution of fragment sizes between 50 and 2000 nts as checked by alkaline agarose gel electrophoresis. Naked DNA controls with a similar distribution of fragment sizes was obtained by treating 30 mg of DNA harvested from ML-1 cells with 0.2 mg/ml DNaseI in 40 mM Tris-HCl, pH 7.7, 10 mM NaCl, 6 mM MgCl 2 for 5 min at room temperature.
LMPCR was performed with the addition of an extension product capture step to enrich for fragments of interest (ToÈ rmaÈ nen et al., 1992). Brie¯y, after 5'-biotinylated primers (identical in sequence to those listed above) were annealed to DNaseI-treated genomic DNA, the primers were extended using Sequenase 2.0 (US Biochemical Corp; Cleveland, Ohio), and ligation of the universal linker was performed as described previously . Streptavidincoated magnetic beads (Dynal; Great Neck, New York) were used to enrich the primer-extended molecules, removing the bulk of the genomic DNA prior to PCR ampli®cation. This step is useful in reducing non-speci®c background by eliminating small genomic DNA fragments generated by DNaseI digestion. The remainder of the LMPCR protocol is as described previously Pfeifer et al., 1993; Pfeifer and Riggs, 1996) .
